An HIV Vaccine in the Era of Twice-Yearly Lenacapavir for PrEP — Essential or Irrelevant?
Lauren P. Jatt, Nyaradzo Mgodi, Susan P. Buchbinder, Glenda Gray, James G. Kublin
Topics & Concepts
Human immunodeficiency virus (HIV)HIV vaccineVirologyMedicineDemographySociologyVaccine trialHIV-related health complications and treatmentsHIV/AIDS Research and InterventionsHIV Research and Treatment